In the last trading session, 1.27 million shares of the Sensei Biotherapeutics Inc (NASDAQ:SNSE) were traded, and its beta was 0.06. Most recently the company’s share price was $0.50, and it changed around $0.05 or 10.69% from the last close, which brings the market valuation of the company to $12.40M. SNSE currently trades at a discount to its 52-week high of $1.94, offering almost -288.0% off that amount. The share price’s 52-week low was $0.38, which indicates that the current value has risen by an impressive 24.0% since then. We note from Sensei Biotherapeutics Inc’s average daily trading volume that its 10-day average is 0.32 million shares, with the 3-month average coming to 337.65K.
Sensei Biotherapeutics Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 7 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 0 recommended SNSE as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Sensei Biotherapeutics Inc is expected to report earnings per share of -0.3 for the current quarter.
Sensei Biotherapeutics Inc (NASDAQ:SNSE) trade information
Instantly SNSE has showed a green trend with a performance of 10.69% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.5615 on recent trading dayincreased the stock’s daily price by 10.95%. The company’s shares are currently down -27.46% year-to-date, but still down -7.04% over the last five days. On the other hand, Sensei Biotherapeutics Inc (NASDAQ:SNSE) is 21.52% up in the 30-day period. We can see from the shorts that 0.19 million shares have been sold at a short interest cover period of 0.29 day(s).
The consensus price target as assigned by Wall Street analysts is $5.5, which translates to bulls needing to increase their stock price by 90.91% from its current value. Analyst projections state that SNSE is forecast to be at a low of $5 and a high of $6.
Sensei Biotherapeutics Inc (SNSE) estimates and forecasts
Sensei Biotherapeutics Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -66.53 percent over the past six months and at a 9.02% annual growth rate that is well below the industry average of 17.50%.
Forecasts for the next quarter put sales growth at �.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -16.26%.
SNSE Dividends
Sensei Biotherapeutics Inc’s next quarterly earnings report is expected to be released in December.
Sensei Biotherapeutics Inc (NASDAQ:SNSE)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 34.39% of Sensei Biotherapeutics Inc shares, and 8.81% of them are in the hands of institutional investors. The stock currently has a share float of 13.43%. Sensei Biotherapeutics Inc stock is held by 23.0 institutions, with IKARIAN CAPITAL, LLC being the largest institutional investor. By 2024-06-30, it held 2.5949% of the shares, which is about 0.65 million shares worth $0.4 million.
VANGUARD GROUP INC, with 2.4702% or 0.62 million shares worth $0.38 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
